Skip to content
FIND A HEALTH VALLEY ACTOR

Vaud: a CHF 90 Million plan to tackle the shortage of healthcare staff

InvestPro Programme Vaud

The Vaud State Council has drawn up a CHF 90 Million “far-reaching plan” to meet the challenges presented by the shortage of healthcare and nursing staff: the InvestPro programme will be based on training, promotion of the professions in the field and retention.     Demographic change, an ageing population and an increase in chronic…

Read More

Transmutex raises CHF 20 Million

Transmutex

The Geneva-based company, founded in 2019, has secured new funding to further develop its research into safer, cleaner and cheaper nuclear power generation. The technology could also have healthcare applications.     Geneva-based nuclear engineering company Transmutex has secured CHF 20 Million in financing from New York-based venture capital funds Union Square Ventures and Steel…

Read More

A CHF 2.5 Million Grant for Diatheris

Diatheris 1

The Leona M. and Harry B. Helmsley Charitable Trust in the United States supports the Diatheris project, a UNIGE spin-off working on an adjunct treatment to boost insulin therapy.     This funding will enable Giorgio Ramadori, a researcher in the Department of Cell Physiology and Metabolism and the Faculty Centre for Diabetes in the…

Read More

HUG wins award for smarter medicine in intensive care

HUG Award

At the 46th World Hospital Congress organised by the International Hospital Federation (IHF), the University Hospitals of Geneva (HUG) received the silver Mastercard Excellence Award in the field of quality of care and patient safety. The award went to the “Smarter medicine in intensive care” project.     Bertrand Levrat, Chief Executive Officer of the…

Read More

HUG Innovation Day: A Pioneer Of New Therapies For Deafness Awarded

HUG Innovation DAY 2023

On the occasion of their 17th Innovation Day, held on 19 October, the Geneva University Hospitals (HUG), in partnership with the Faculty of Medicine of the University of Geneva (UNIGE), awarded the 2023 Innovation Prize to the project “The Phoenix platform – a catalyst for the development of new therapies for deafness” and two trophies…

Read More

Medicrops acquires Swiss Alpinopharma

Medicrops

A strategic move to enhance digital patient care in the booming European cannabis market.     MediCrops Holding AG (‘MediCrops’), based in Schwyz and at Biopôle in Lausanne, has acquired Berlin-based company Swiss Alpinopharma GmbH (‘Swiss Alpinopharma’), a disruptive market leader in the field of medical cannabis and owner of telemedicine platform Enmedify. Swiss Alpinopharma…

Read More

Tune Insight raises CHF 3,1 Million

Tune Insight

The round is led by 14Peaks Capital, with participation from investors including Inflection.xyz, Debiopharm Innovation Fund and Zurich Cantonal Bank. Existing investor Wingman Ventures has also contributed.     How to share data, without sharing it, and still be compliant with RGPD and data protection laws. Tune Insight is working on a solution! The EPFL…

Read More

CHUV@home: an application to monitor patients after surgery

CHUV@home

Nearly 1,800 people have already used the CHUV@home application since it was launched in 2021. Patients who have undergone surgery can benefit from 24-hour remote monitoring by the nursing team at the CHUV’s Centre de télésuivi.     Getting patients home safely is a priority for the CHUV. The CHUV@home application provides support and assistance…

Read More

Innovation at Hôpital de la Tour

4à6 La Tour

On Thursday 1 June, the Swiss Health Valley Community was received by Hôpital de la Tour in Meyrin during a BioAlps 4à6 event. The 70 participants discovered the “Value Based Health Care” strategy implemented by the hospital and the ambitious project of health campus. They also had the opportunity to visit the radio-oncology and the…

Read More

Le Temps – Medtechs still trapped in European reform on medical devices

Le Temps - Medtech

Medical technology companies are still grappling with the new rules on healthcare devices and diagnostics, two years after they came into force. These changes are costly and time-consuming.   ⚠️ This article was written by Etienne Meyer-Vacherand and was originally published in French in Le Temps.    Two years on, the chaos caused by the…

Read More